07917067 1.2.12 31.1.13 31.1.13 Company accounts Private Limited Company FY true false true false true false false false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure079170672012-01-31079170672013-01-31079170672012-02-012013-01-31079170672012-01-3107917067ns12:England2012-02-012013-01-3107917067ns14:PoundSterling2012-02-012013-01-3107917067ns7:Director12012-02-012013-01-3107917067ns7:OrdinaryShareClass12012-02-012013-01-3107917067ns7:CompanySecretary2012-02-012013-01-3107917067ns7:RegisteredOffice2012-02-012013-01-3107917067ns7:EntityAccountantsOrAuditors2012-02-012013-01-3107917067ns7:OrdinaryShareClass12013-01-31
REGISTERED NUMBER: 07917067 (England and Wales)















ABBREVIATED UNAUDITED ACCOUNTS FOR THE YEAR ENDED 31 JANUARY 2013

FOR

SYNERGY BIOMEDICAL LIMITED
SYNERGY BIOMEDICAL LIMITED (REGISTERED NUMBER: 07917067)






CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 JANUARY 2013




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3
SYNERGY BIOMEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2013







DIRECTOR: Dr E V Howman





SECRETARY:





REGISTERED OFFICE: 17 Summerfield
Oxford
Oxfordshire
OX1 4RU





REGISTERED NUMBER: 07917067 (England and Wales)





ACCOUNTANTS: Jamesons Limited
Jamesons House
Compton Way
Witney
Oxfordshire
OX28 3AB
SYNERGY BIOMEDICAL LIMITED (REGISTERED NUMBER: 07917067)

ABBREVIATED BALANCE SHEET
31 JANUARY 2013

Notes £    £   
FIXED ASSETS
Tangible assets 2 939

CURRENT ASSETS
Debtors 4,614
Cash at bank 32,662
37,276
CREDITORS
Amounts falling due within one year 13,979
NET CURRENT ASSETS 23,297
TOTAL ASSETS LESS CURRENT LIABILITIES 24,236

CAPITAL AND RESERVES
Called up share capital 3 1
Profit and loss account 24,235
SHAREHOLDERS' FUNDS 24,236

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2013.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2013 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a) ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 5 April 2013 and were signed by:





Dr E V Howman - Director

SYNERGY BIOMEDICAL LIMITED (REGISTERED NUMBER: 07917067)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 JANUARY 2013

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.


Plant and machinery etc - 33% on cost, 25% on reducing balance

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
Additions 1,308
At 31 January 2013 1,308
DEPRECIATION
Charge for year 369
At 31 January 2013 369
NET BOOK VALUE
At 31 January 2013 939

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1

1 Ordinary share of £1 was allotted and fully paid for cash at par during the year.

Options

Monitor

  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
Monitor Now

Please Help Us!

Was this document useful to you? Please Like our page. The more Likes we get, the more documents we can supply you free. Thanks.